Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Tweddle

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
British Journal of Haematology|December 19, 1998
Cerebral candidiasis in a child 1 year after leukaemiaD A Tweddle, J C Graham, G S Shankland, et al.
Oncogene|July 5, 2011
MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63L D Gamble, U R Kees, D A Tweddle, et al.
Cancer Research|February 24, 2001
Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell lineD A Tweddle, A J Malcolm, N Bown, et al.
Archives of Disease in Childhood|July 1, 1997
Central venous catheter use in UKCCSG oncology centres. United Kingdom Children's Cancer Study Group and the Paediatric Oncology Nursing ForumD A Tweddle, K P Windebank, A M Barrett, et al.
The American Journal of Pathology|June 8, 2001
p53 cellular localization and function in neuroblastoma: evidence for defective G(1) arrest despite WAF1 induction in MYCN-amplified cellsD A Tweddle, A J Malcolm, M Cole, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 3, 1998
Non-tuberculous mycobacterial infection in children with cancerJ C Graham, D A Tweddle, D R Jenkins, et al.
Journal of Clinical Pathology|March 28, 2006
Limitations in the ability of NB84 to detect metastatic neuroblastoma cells in bone marrowS N Bomken, K Redfern, K M Wood, et al.
Medical and Pediatric Oncology|July 24, 2001
OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of ageD A Tweddle, C R Pinkerton, I J Lewis, et al.
Transplantation|June 9, 1999
Posttransplantation B lymphoblastic leukemia with Burkitt-like featuresD A Tweddle, A R Gennery, M M Reid, et al.
British Journal of Cancer|June 13, 2014
Structurally diverse MDM2-p53 antagonists act as modulators of MDR-1 function in neuroblastomaL Chen, Y Zhao, G C Halliday, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
British Journal of Haematology|December 19, 1998
Cerebral candidiasis in a child 1 year after leukaemiaD A Tweddle, J C Graham, G S Shankland, et al.
Oncogene|July 5, 2011
MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63L D Gamble, U R Kees, D A Tweddle, et al.
Cancer Research|February 24, 2001
Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell lineD A Tweddle, A J Malcolm, N Bown, et al.
Archives of Disease in Childhood|July 1, 1997
Central venous catheter use in UKCCSG oncology centres. United Kingdom Children's Cancer Study Group and the Paediatric Oncology Nursing ForumD A Tweddle, K P Windebank, A M Barrett, et al.
The American Journal of Pathology|June 8, 2001
p53 cellular localization and function in neuroblastoma: evidence for defective G(1) arrest despite WAF1 induction in MYCN-amplified cellsD A Tweddle, A J Malcolm, M Cole, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 3, 1998
Non-tuberculous mycobacterial infection in children with cancerJ C Graham, D A Tweddle, D R Jenkins, et al.
Journal of Clinical Pathology|March 28, 2006
Limitations in the ability of NB84 to detect metastatic neuroblastoma cells in bone marrowS N Bomken, K Redfern, K M Wood, et al.
Medical and Pediatric Oncology|July 24, 2001
OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of ageD A Tweddle, C R Pinkerton, I J Lewis, et al.
Transplantation|June 9, 1999
Posttransplantation B lymphoblastic leukemia with Burkitt-like featuresD A Tweddle, A R Gennery, M M Reid, et al.
British Journal of Cancer|June 13, 2014
Structurally diverse MDM2-p53 antagonists act as modulators of MDR-1 function in neuroblastomaL Chen, Y Zhao, G C Halliday, et al.
Pageof 2